Κλινικές Μελέτες

EpcoReal: A Multi-country, Prospective Observational Study of Epcoritamab in NHL Comprising Two Patient Cohorts (3L+ (D)LBCL and 3L+ FL)

Protocol No
P24-903

Trial information

Medical condition
3L+DLBCL/FL
Trial phase
Observational
Sponsor
AbbVie Inc.
Start date
21/03/2025
Main objective
ORR within 12 months

Locations and Contact points

Greece

Site city Organisation name Department name Name Email Telephone number
Alexandroupolis University General Hospital of Alexandroupolis Hematology Clinic Ioannis Kotsianidis 2551353154